Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
A randomised, controlled trial of a dietary intervention for adults with major depression (the "SMILES" trial): study protocol

O'Neil A, Berk M, Itsiopoulos C, Castle D, Opie R, Pizzinga J, Brazionis L, Hodge A, Mihalopoulos C, Chatterton ML, Dean OM, Jacka FN

(2013), BMC Psychiatry, 13, 114

Mind your language: conveying the results of clinical trials of cardiovascular therapies

Krum H, Lang C

(2013), Cardiovasc Ther, 31(1), 1

Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm

Hopper I, Skiba M, Krum H

(2013), Eur J Heart Fail, 15(1), 69-78

Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design

Kotecha D, Manzano L, Altman DG, Krum H, Erdem G, Williams N, Flather MD; Beta-Blockers in Heart Failure Collaborative Group

(2013), Syst Rev, 2, 7

Influence of background treatment with mineralocorticoid receptor antagonists on ivabradine’s effects in patients with chronic heart failure

Komajda M, Böhm M, Borer J, Ford I, Krum H, Tase A, Tavazzi L, Swedberg K

(2013), Eur J Heart Fail, 15(1), 79-84

Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction

Connelly KA, Advani A, Advani S, Zhang Y, Thai K, Thomas S, Krum H, Kelly DJ, Gilbert RE

(2013), Cardiovasc Ther, 31(2), 84-91

Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial

Dobre D, Rossignol P, Murin J, Parkhomenko A, Lamiral Z, Krum H, van Veldhuisen DJ, Pitt B, Zannad F

(2013), Eur J Heart Fail, 15(2), 221-7

N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: results of the SCReening Evaluation of the Evolution of New-Heart Failure Study (SCREEN-HF)

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Krum H

(2013), Eur J Heart Fail, 15(5), 573-80

Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome

Liu S, Kompa AR, Kumfu S, Nishijima F, Kelly DJ, Krum H, Wang BH

(2013), Int J Cardiol, 168(3), 1866-8

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study

Wong YW, Thomas L, Sun JL, McMurray JJ, Krum H, Hernandez AF, Rutten GE, Leiter LA, Standl E, Haffner SM, Mazzone T, Martinez FA, Tognoni G, Giles T, Califf RM

(2013), Circ Heart Fail, 6(2), 203-10

Barriers to achieving blood pressure treatment targets in elderly hypertensive individuals

Chowdhury EK, Owen A, Krum H, Wing LM, Ryan P, Nelson MR, Reid CM; Second Australian National Blood Pressure Study Management Committee

(2013), J Hum Hypertens, 27(9), 545-51

Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease

Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, Böhm M, Lambert EA, Krum H, Sobotka PA, Schmieder RE, Ika-Sari C, Eikelis N, Straznicky N, Lambert GW, Esler M

(2013), Int J Cardiol, 168(3), 2214-20

Prophylaxis against atrial fibrillation after cardiac surgery: beneficial effect of perioperative metoprolol

Skiba MA, Pick AW, Chaudhuri K, Bailey M, Krum H, Kwa LJ, Rosenfeldt FL

(2013), Heart Lung Circ, 22(8), 627-33

Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from the WHICH? Trial

Whitty JA, Stewart S, Carrington MJ, Calderone A, Marwick T, Horowitz JD, Krum H, Davidson PM, Macdonald PS, Reid C, Scuffham PA

(2013), PLoS One, 8(3), e58347

Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Lonn EM, Bosch J, Diaz R, Lopez-Jaramillo P, Ramachandran A, Hâncu N, Hanefeld M, Krum H, Ryden L, Smith S, McQueen MJ, Dyal L, Yusuf S, Gerstein HC; GRACE and ORIGIN Investigators

(2013), Diabetes Care, 36(9), 2466-74

Response to quality of life after renal denervation

Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, Shaw J, Krum H, Dixon JB, Barton DA, Schlaich MP

(2013), Hypertension, 61(4), e39

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F

(2013), Eur Heart J, 34(31), 2453-63

Renal nerve ablation reduces augmentation index in patients with resistant hypertension

Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP

(2013), J Hypertens, 31(9), 1893-900

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure

von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC Jr, Krum H

(2013), Circ Heart Fail, 6(3), 594-605

Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study

Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F; EMPHASIS-HF Study Group

(2013), Circ Heart Fail, 6(4), 711-8

434 435 436 437 438